Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för lipoic acid, alpha. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

7 träffar

Bibliografisk träff 2023-10-16

Discovery of novel β-elemene hybrids with hydrogen sulfide-releasing moiety possessing cardiovascular protective activity for the treatment of atherosclerosis.

Zhu W, Wu H, He C, Zhu H, Yao H, Cao Y, Shi Y, Chen X, Feng X, Xu S, Zhu Z, Xu J.

RSC Med Chem · research-article; journal article · DOI 10.1039/d3md00447c

Bibliografisk träff 2023-07-19

A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.

Sutherland JJ, Yonchev D, Fekete A, Urban L.

Nat Commun · research support, non-u.s. gov't; research-article; journal article · DOI 10.1038/s41467-023-40064-9

Bibliografisk träff 2022-01-31

Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of Candidiasis.

Wen W, Cao H, Huang Y, Tu J, Wan C, Wan J, Han X, Chen H, Liu J, Rao L, Su C, Peng C, Sheng C, Ren Y.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.1c02102

Bibliografisk träff 2021-08-13

Boron-based hybrids as novel scaffolds for the development of drugs with neuroprotective properties.

Cacciatore I, Turkez H, Di Rienzo A, Ciulla M, Mardinoglu A, Di Stefano A.

RSC Med Chem · research-article; journal article · DOI 10.1039/d1md00177a

Bibliografisk träff 2019-09-10

Antioxidant-Conjugated 1,2,4-Triazolo[4,3-a]pyrazin-3-one Derivatives: Highly Potent and Selective Human A2A Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain.

Falsini M, Catarzi D, Varano F, Ceni C, Dal Ben D, Marucci G, Buccioni M, Volpini R, Di Cesare Mannelli L, Lucarini E, Ghelardini C, Bartolucci G, Menicatti M, Colotta V.

J Med Chem · research support, non-u.s. gov't; journal article · DOI 10.1021/acs.jmedchem.9b00778

Bibliografisk träff 2019-06-06

Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.

Li H, Gao X, Huang X, Wang X, Xu S, Uchita T, Gao M, Xu J, Hua H, Li D.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2019.06.016

Bibliografisk träff 2017-06-07

Syntheses, toxicities and anti-inflammation of H2S-donors based on non-steroidal anti-inflammatory drugs.

Li M, Li J, Zhang T, Zhao Q, Cheng J, Liu B, Wang Z, Zhao L, Wang C.

Eur J Med Chem · journal article · DOI 10.1016/j.ejmech.2017.06.012

Gå till forskningen.

Publikationer i urvalet

Discovery of novel β-elemene hybrids with hydrogen sulfide-releasing moiety possessing cardiovascular protective activity for the treatment of atherosclerosis.

A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs.

Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of <i>Candidiasis</i>.

Boron-based hybrids as novel scaffolds for the development of drugs with neuroprotective properties.

Antioxidant-Conjugated 1,2,4-Triazolo[4,3-<i>a</i>]pyrazin-3-one Derivatives: Highly Potent and Selective Human A<sub>2A</sub> Adenosine Receptor Antagonists Possessing Protective Efficacy in Neuropathic Pain.

Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties.

Syntheses, toxicities and anti-inflammation of H<sub>2</sub>S-donors based on non-steroidal anti-inflammatory drugs.